ASCO GU 2023 Conference Coverage
Playback speed
10 seconds
ASCO GU 2023 Assessment of Clavien-Dindo Classification in Patients With Metastatic Clear Cell RCC Who Received Perioperative Cabozantinib and Nivolumab on the Cyto-KIK Clinical Trial
By
ASCO GU 2023 Conference Coverage
FEATURING
Karie Runcie
By
ASCO GU 2023 Conference Coverage
FEATURING
Karie Runcie
76 views
March 8, 2023
Login to view comments.
Click here to Login
Videos